PERITONEAL MALIGNANT MESOTHELIOMA
Clinical trials for PERITONEAL MALIGNANT MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new PERITONEAL MALIGNANT MESOTHELIOMA trials appear
Sign up with your email to follow new studies for PERITONEAL MALIGNANT MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune booster shows promise against rare cancer
Disease control CompletedThis study tested a drug called pembrolizumab in 65 people with malignant mesothelioma, a rare cancer of the lining around the lungs or abdomen. The drug works by helping the immune system attack cancer cells. The goal was to see if it could shrink tumors or slow the disease, but…
Matched conditions: PERITONEAL MALIGNANT MESOTHELIOMA
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New hope for mesothelioma patients who Can't have surgery?
Disease control CompletedThis study tested a chemotherapy drug called paclitaxel, given directly into the abdomen, for people with a rare cancer called malignant peritoneal mesothelioma. The 7 participants could not have standard surgery. The main goal was to find the safest dose and see if the treatment…
Matched conditions: PERITONEAL MALIGNANT MESOTHELIOMA
Phase: PHASE1, PHASE2 • Sponsor: Erasmus Medical Center • Aim: Disease control
Last updated Jun 26, 2026 13:22 UTC